ALFA FinderNSE filing, NSE: VILINBIO. Summary written from the filing by ALFA Finder's alert engine.
Vilin Bio Med Ltd: key numbers
- Share price
- ₹52.00
- Market cap
- ₹79.30 Cr
- Revenue (annual)
- ₹42.26 Cr
- Net profit (annual)
- ₹1.93 Cr
- P/E (TTM)
- 41.1×Sector 43.8×
- Promoter holding
- 56.65%+0.00% QoQ
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vilin Bio Med Ltd
All →Vilin Bio Med Other Announcement
Vilin Bio Med voluntarily filed its Integrated Corporate Governance Report for the quarter ended September 30, 2026, despite being exempt as an NSE Emerge listed entity. No material business transaction or decision is disclosed.
Vilin Bio Med Acquisition
Vilin Bio Med held NCLT-convened meetings to approve a scheme of amalgamation with Chemgenix Laboratories. Voting results remain pending in the Scrutinizer's report.
Vilin Bio Med Merger & Restructuring
Vilin Bio Med Limited announced an NCLT-convened meeting on October 15, 2026, to vote on a Scheme of Arrangement with Chemgenix Laboratories Private Limited.
Vilin Bio Med Board Meeting Date
Vilin Bio Med Limited scheduled a board meeting for September 18, 2026, to consider an amalgamation proposal. Trading window remains closed until September 20, 2026.
Vilin Bio Med Acquisition
Vilin Bio Med disclosed NCLT Hyderabad allowed its amalgamation with Chemgenix Laboratories Pvt Ltd. The order directs convening shareholder and creditor meetings for both companies.
Vilin Bio Med Annual General Meeting
Vilin Bio Med Limited conducted its 20th Annual General Meeting on September 2, 2026, to discuss financial statements, director appointments, and related party transactions.
Other promoter reclassification announcements
All →Nova Iron & Steel Promoter Reclassification
Nova Iron & Steel received a request from promoter group entities holding 0% to be reclassified as Public under Regulation 31A. The board will consider the reclassification request, subject to stock exchange approval.
Shekhawati Industries Promoter Reclassification
Shekhawati Industries received BSE and NSE no-objection to reclassify Altius Buildcon from promoter group to public, effective 9 November 2026. Altius holds no shares.
Umiya Tubes Promoter Reclassification
Umiya Tubes received reclassification requests from two promoter group members to move to public category. Both hold nil shares and seek approval under Regulation 31A.
Baba Arts Promoter Reclassification
Baba Arts' board noted promoters Gordhan and Rahul Tanwani's request to reclassify as public shareholders. Company Secretary Naishadh Mankad resigned and Shilpi Shukla was appointed.
Vaxtex Cotfab Promoter Reclassification
Vaxtex Cotfab received NSE approval to reclassify Bharti Kailash Gupta, holding 0.40%, from promoter group to public. The change took effect on 5 November 2026.
Shri Gang Industries and Allied Products Promoter Reclassification
Shri Gang Industries received BSE no-objection for reclassifying four Gupta family members from promoter to public category under Regulation 31A. Shareholder approval is still required, and no monetary value is involved.